ENTITY
Ilyang Pharmaceutical Co.,

Ilyang Pharmaceutical Co., (007570 KS)

34
Analysis
Health Care • South Korea
Il Yang Pharmaceutical Co., Ltd. manufactures a wide range of drugs acting on the digestive system, respiratory system, and circulatory system. The Company also produces antipyretic, analgesic, anti-inflammatory, and nutritional agents, tranquilizers, health food, insecticides, cosmetics, pharmaceutical raw materials, and therapeutic agents for liver and kidney disease.
more
bearish•Cross Asset Strategy
•31 Mar 2020 17:32

Korea Stock Market Monthly Recap #46 (March 2020)

The world will never be the same after COVID-19. We provided an extensive analysis of the on-going developments of COVID-19 in March. This novel...

Logo
400 Views
Share
bullish•Hanjin KAL Corp
•01 Mar 2020 12:14

KOSPI200 Rebalance Preview - Changing Names in a Volatile Market

The Korea Exchange (KRX) will announce the results of the June 2020 review of the KOSPI 200 in May. The constituent changes will be effective from...

Logo
485 Views
Share
bullish•Posco Future M
•10 Feb 2020 13:01

KOSPI200 Rebalance Preview - The Early Bird Gets the Worm

The Korea Exchange (KRX) will announce the results of the June 2020 review of the KOSPI 200 in May. The constituent changes will be effective from...

Logo
611 Views
Share
bearish•Celltrion Inc
•10 Aug 2017 19:54

NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move

Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...

Logo
1.6k Views
Share
•08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.1k Views
Share
x